Linda K. Han

Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

Steven M. Rowe, Cori Daines, Felix C. Ringshausen et al. · New England Journal of Medicine · 2017 · 511 citations · Full text

Medicine, Genetics, Molecular Genetics +13

A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072

Rache M. Simmons, Karla V. Ballman, Charles Cox et al. · Annals of Surgical Oncology · 2016 · 165 citations · Full text

Medicine, Oncology, Breast Oncology +3

A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer

Lori J. Goldstein, Raymond P. Perez, Denise A. Yardley et al. · Breast Cancer Research · 2020 · 137 citations · Full text

Medicine, Oncology, Pharmacology +17

Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial

Richard E. Fine, Richard C. Gilmore, Jill R. Dietz et al. · Annals of Surgical Oncology · 2021 · 119 citations

Medicine, Oncology, Surgery +9

Comparative Evaluation of [99mTc]Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials

Anne M. Wallace, Linda K. Han, Stephen P. Povoski et al. · Annals of Surgical Oncology · 2013 · 113 citations · Full text

Medicine, Oncology, Surgery +17